Project
A randomized, double-blind, placebo controlled Phase
Completed ยท 2009 until 2010
Heinzerling Lucie
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Completed
Start Date
2009
End Date
2010
Financing
Industry
Brief description/objective
A randomized, double-blind, placebo controlled Phase
II, multi-centre study of the efficacy and safety of CT
327, a topical cream formulation of Pegylated K252a,
when administered twice daily for eight weeks to
patients with mild to moderate Psoriasis Vulgaris